Oxadiazoles in Medicinal Chemistry

被引:529
|
作者
Bostrom, Jonas [1 ]
Hogner, Anders [1 ]
Llinas, Antonio [1 ]
Wellner, Eric [1 ]
Plowright, Alleyn T. [1 ]
机构
[1] AstraZeneca R&D, S-43183 Molndal, Sweden
关键词
DRUG-LIKE PROPERTIES; RECEPTOR ANTAGONISTS; CARBOXYLIC-ACIDS; DISCOVERY; 1,3,4-OXADIAZOLES; INHIBITORS; LIPOPHILICITY; PHARMACOLOGY; REPLACEMENTS; SELECTIVITY;
D O I
10.1021/jm2013248
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms. Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities. The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection. In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner. Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers. The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments). To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.
引用
收藏
页码:1817 / 1830
页数:14
相关论文
共 50 条
  • [41] Sulfonimidamides in Medicinal and Agricultural Chemistry
    Chinthakindi, Praveen K.
    Naicker, Tricia
    Thota, Niranjan
    Govender, Thavendran
    Kruger, Hendrik G.
    Arvidsson, Per I.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (15) : 4100 - 4109
  • [42] Expanding medicinal chemistry space
    Barker, Andy
    Kettle, Jason G.
    Nowak, Thorsten
    Pease, J. Elizabeth
    DRUG DISCOVERY TODAY, 2013, 18 (5-6) : 298 - 304
  • [43] Fluoroalkyl-Containing 1,2-Disubstituted Cyclobutanes: Advanced Building Blocks for Medicinal Chemistry
    Demchuk, Oleksandr P.
    Hryshchuk, Oleksandr V.
    Vashchenko, Bohdan V.
    Trofymchuk, Serhii A.
    Melnykov, Kostiantyn P.
    Skreminskiy, Artem
    Volochnyuk, Dmitriy M.
    Grygorenko, Oleksandr O.
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2021, 2021 (01) : 87 - 95
  • [44] 1,4-benzodiazepin-2-ones in medicinal chemistry
    Spencer, John
    Rathnam, Rajendra P.
    Chowdhry, Babur Z.
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (09) : 1441 - 1449
  • [45] Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects
    Liu, Y.
    Hu, Y.
    Liu, T.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (23) : 3982 - 3999
  • [46] Evolution of a thienopyrimidine antitubercular relying on medicinal chemistry and metabolomics insights
    Li, Shao-Gang
    Vilcheze, Catherine
    Chakraborty, Sumit
    Wang, Xin
    Kim, Hiyun
    Anisetti, Monica
    Ekins, Sean
    Rhee, Kyu Y.
    Jacobs, William R., Jr.
    Freundlich, Joel S.
    TETRAHEDRON LETTERS, 2015, 56 (23) : 3246 - 3250
  • [47] Medicinal Chemistry Profiling of Monocyclic 1,2-Azaborines
    Zhao, Peng
    Nettleton, David O.
    Karki, Rajeshri G.
    Zecri, Frederic J.
    Liu, Shih-Yuan
    CHEMMEDCHEM, 2017, 12 (05) : 358 - 361
  • [48] IS THERE ANYTHING NEW ABOUT THE MOLECULAR RECOGNITION APPLIED TO MEDICINAL CHEMISTRY?
    Fokoue, Harold H.
    Pinheiro, Pedro S. M.
    Fraga, Carlos A. M.
    Sant'Anna, Carlos M. R.
    QUIMICA NOVA, 2020, 43 (01): : 78 - 89
  • [49] The recent progress of isoxazole in medicinal chemistry
    Zhu, Jie
    Mo, Jun
    Lin, Hong-zhi
    Chen, Yao
    Sun, Hao-peng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (12) : 3065 - 3075
  • [50] Ferrocenes in medicinal chemistry; a personal perspective
    Sansook, Supojjanee
    Hassell-Hart, Storm
    Ocasio, Cory
    Spencer, John
    JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2020, 905